Impact on postoperative bleeding and cost of recombinant activated factor VII in patients undergoing heart transplantation

BACKGROUND: Cardiac transplantation can be complicated by refractory hemorrhage particularly in cases where explantation of a ventricular assist device is necessary. Recombinant activated factor VII (rFVIIa) has been used to treat refractory bleeding in cardiac surgery patients, but little informati...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollis, Allison L., Lowery, Ashleigh V., Pajoumand, Mehrnaz, Pham, Si M., Slejko, Julia F., Tanaka, Kenichi A., Mazzeffi, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971969/
https://www.ncbi.nlm.nih.gov/pubmed/27397445
http://dx.doi.org/10.4103/0971-9784.185523

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971969/
https://www.ncbi.nlm.nih.gov/pubmed/27397445
http://dx.doi.org/10.4103/0971-9784.185523

Ejemplares similares